LRCX
55
6
FITB
58
5
XEL
69
7
NUE
47
3
NDAQ
59
4
TJX
48
11
MET
70
6
GE
64
6
KLAC
63
6
IBM
57
2
HON
58
3
GLW
49
3
HP
36
3
CMCSA
48
2
PPL
80
5
VLO
45
3
ADSK
43
3
F
55
3
MHK
42
-6
QCOM
56
5
LRCX
55
6
FITB
58
5
XEL
69
7
NUE
47
3
NDAQ
59
4
TJX
48
11
MET
70
6
GE
64
6
KLAC
63
6
IBM
57
2
HON
58
3
GLW
49
3
HP
36
3
CMCSA
48
2
PPL
80
5
VLO
45
3
ADSK
43
3
F
55
3
MHK
42
-6
QCOM
56
5
Financhill
Back

Haemonetics Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
58

HAE
Haemonetics

Last Price:
$65.47
Seasonality Move:
1%

7 Day Trial

ALL ACCESS PASS

$ 7

Should You Invest in this AI Marketing High-Growth Startup by April?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.

Haemonetics Stock Forecast

  • Over the next 52 weeks, Haemonetics has on average historically risen by 11.7% based on the past 33 years of stock performance.
  • Haemonetics has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Haemonetics Stock Undervalued?
    The current Haemonetics [HAE] share price is $65.52. The Score for HAE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • HAE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Haemonetics Stock Go Up Next Year?

  • Over the next 52 weeks, Haemonetics has on average historically risen by 11.7% based on the past 33 years of stock performance.

Haemonetics Stock Rating

Buy
58
Haemonetics (HAE) is a Buy

Is Haemonetics overpriced?

  • Haemonetics has risen higher in 22 of those 33 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Haemonetics Stock Price History

Is HAE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HAE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
haemonetics.com

52-Week Data

52-Week High:
97.97
52-Week Low:
58.80

Prediction Charts

Market Cap:
3.3B
Price in USD:
65.52
Volume:
1M
Beta:
0.45

Technical Analysis

SMA50:
69.47
SMA100:
75.37
SMA200:
78.55
52-Wk Change:
-13.33%

Stock Predictions

  • Is Haemonetics stock public?
    Yes, Haemonetics is a publicly traded company.
  • What is the Haemonetics stock quote today?
    The Haemonetics stock price is 65.52 USD today.
  • How to buy Haemonetics stock online?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-21 63.29 63.02 64.31 62.38
Feb-25 66.18 65.39 66.18 64.16
Feb-26 65.33 64.93 65.58 64.33
Feb-27 64.96 64.57 66.02 64.08
Feb-28 64.50 65.50 66.62 64.25
Mar-3 65.49 65.08 67.09 64.54
Mar-4 65.44 66.00 67.04 64.25
Mar-5 66.64 67.16 68.20 65.94
Mar-6 66.82 67.20 68.35 66.17
Mar-7 66.78 68.70 69.27 65.96
Mar-11 67.19 68.30 68.91 66.66
Mar-12 68.38 65.68 68.38 65.07
Mar-13 65.66 65.93 67.50 65.28
Mar-14 66.00 65.52 67.03 65.28

Haemonetics Earnings

Haemonetics Earnings Report: Per Share Haemonetics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Haemonetics Forecast Revenue Growth

Haemonetics Stock Analysis: Historical quarterly revenues per share for Haemonetics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.09 per share, an increase this year of $0.59 per share, and an increase next year of $0.44 per share.

* Haemonetics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.